Table 2.
Subgroup analysis: prevalence of declared and actual public data sharing according to type of data and journal policy
Policy | Declared data sharing | Actual data sharing | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Sharing prevalence (%) | 95% CI (%) | 95% PI (%) | k | I2 | Sharing prevalence (%) | 95% CI (%) | 95% PI (%) | k | I2 (%) | ||
No data restrictions: | |||||||||||
No policy | 17* | 0 to 59 | NA | 4 | 95 | 4* | 0 to 95 | NA | 2 | 83 | |
Encourage policy | 17* | 0 to 62 | 0 to 100 | 6 | 98 | 8* | 0 to 48 | NA | 3 | 90 | |
Mandatory policy | 65* | 36 to 88 | 2 to 100 | 5 | 99 | 33* | 5 to 69 | NA | 3 | 93 | |
Sequence data: | |||||||||||
No policy | — | — | — | — | — | 46* | 0 to 100 | NA | 2 | 94 | |
Encourage policy | — | — | — | — | — | 57* | 15 to 94 | NA | 2 | 0 | |
Mandatory policy | — | — | — | — | — | 67* | 45 to 86 | NA | 3 | 70 | |
Gene expression data: | |||||||||||
No policy | 23 | 11 to 42 | NA | 1 | NA | — | — | — | — | — | |
Encourage policy | 30 | 19 to 44 | NA | 1 | NA | 43 | 31 to 55 | NA | 1 | NA | |
Mandatory policy | 69* | 0 to 100 | NA | 2 | 93 | 43* | 0 to 100 | NA | 2 | 53 | |
Trial data: | |||||||||||
No policy | 0* | 0 to 46 | NA | 2 | 72 | — | — | — | — | — | |
Encourage policy | 0* | 0 to 5 | NA | 3 | 24 | — | — | — | — | — | |
Mandatory policy | 55* | 40 to 70 | NA | 2 | 0 | 56 | 33 to 77 | NA | 1 | NA | |
Systematic review data: | |||||||||||
No policy | 5* | 2 to 8 | NA | 2 | 0 | 0 | 0 to 4 | NA | 1 | NA | |
Encourage policy | 3* | 0 to 100 | NA | 2 | 87 | 1 | 0 to 4 | NA | 1 | NA | |
Mandatory policy | 62* | 0 to 100 | NA | 2 | 92 | 28 | 16 to 44 | NA | 1 | NA |
CI=confidence interval; PI=prediction interval; k=number of eligible meta-research studies; NA=not applicable.
Pooled estimate from random effects meta-analysis.